Red List

CRBPCorbus Pharmaceuticals Holdings

Healthcare · Biotechnology · micro-cap ($168M)
-52.1%
from rolling 252-day high of $20.56 set 2025-10-20 · 304d ago
Current
$9.84
Decline depth
-52.1%
Decline σ
3.2σ
TFC
2/5 bearish
Rolling 252-day high Up day Down day Last 90 trading days · data from Alpaca

Since tracking began

$CRBP has been tracked since 2026-03-01. It was down 59.4% from its 52-week high then — now down -52.1%.

It has clawed back 9.9 percentage points off that level. It bottomed 64.1% below that high along the way.

Decline from the 52-week high as it stood on 2026-03-02 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.

Structural break signals

CRBP qualifies for the Red List on decline depth.

Decline depth
-52.1%
From rolling 252-day high of $20.56, 304d ago. Past the 40% Red List threshold.
Time-frame continuity
2/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Decline sigma
3.2σ
Drop from local high over the last 5 bars, expressed in units of the stock's typical daily volatility (2.94% per day).

The structural read

What price action says about CRBP.

CRBP qualifies for the Red List on decline depth — down -52.1% from its rolling 252-day high. Past the 40% threshold, the deepest tier in the taxonomy.

Upstream TFC read: weak alignment, current phase daily. Last bar types — daily 2D (red), weekly 2U (red), monthly 2U (green).

Earnings on file: 2026-05-12. Tiering is unaffected by earnings dates — listings reflect price structure only.

Questions about CRBP

What people ask.

Why is CRBP on Broken Stocks?

CRBP qualifies for the Red List on decline depth. It is down -52.1% from its rolling 252-day high of $20.56, set on 2025-10-20 — 304d ago.

Is CRBP a falling knife?

Not by the strict technical definition. CRBP is down -52.1% from its 52-week high, but that high was set 304d ago — more than 120 days. A falling knife is usually a recent breakdown from a fresh high, not an established multi-quarter downtrend. CRBP is still on the Red List for decline depth, but the freshness component of a falling knife is missing.

Is CRBP a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is CRBP trading inside its 52-week range?

At $9.84, CRBP sits 20.2% of the way from its 52-week low ($7.12) to its 52-week high ($20.56). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has CRBP been declining?

The current 52.1% decline accrued over 304d, which annualizes to roughly -62.6% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does CRBP compare to its sector?

There are 143 other Healthcare tickers on Broken Stocks: 69 Red, 35 Amber, 39 Watch, with 50 showing recovering structural signals. Median sector decline is -36.1% — CRBP's decline is deeper than the sector median.

Does CRBP's earnings date affect its tier?

No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-05-12) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.